Back to mobile site

Jefferies Reiterates Buy Rating on IGM Biosciences (IGMS)

October 1, 2024 6:16 AM EDT Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $48.00 price target on IGM Biosciences (NASDAQ: IGMS)The analyst comments "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login